| User's Publication |
|
21718
Kudo K, Yanagiya R, Hasegawa M, Carreras J, Miki Y, Nakayama S, Nagashima E, Miyatake Y, Torii K, Ando K, Nakamura N, Miyajima A, Murakami M, Kotani A.
Unique lipid composition maintained by extracellular blockade leads to prooncogenicity.
Cell Death Discov
2024
10(1):221
PubMed ID: 38719806
DOI: 10.1038/s41420-024-01971-y
|
|
19770
Mitobe Y, Suzuki S, Nakagawa-Saito Y, Togashi K, Sugai A, Sonoda Y, Kitanaka C, Okada M.
Antagonizing MDM2 Overexpression Induced by MDM4 Inhibitor CEP-1347 Effectively Reactivates Wild-Type p53 in Malignant Brain Tumor Cells
Cancers (Basel)
2023
15(17):4326
PubMed ID: 37686602
DOI: 10.3390/cancers15174326
|
|
21053
Kakuo M, Horii T, Tonomura N, Sato R, Ogawa M, Okajima T, Kamemura K
Evidence that only EWS among the FET proteins acquires a low partitioning property for the hyperosmotic stress response by O-GlcNAc glycosylation on its low-complexity domain.
Exp Cell Res
2023
424(1):113504
PubMed ID: 36736606
DOI: 10.1016/j.yexcr.2023.113504
|
|
20548
Tamura Y, Nakamizo Y, Watanabe Y, Kimura I, Katoh H.
Filamin A forms a complex with EphA2 and regulates EphA2 serine 897 phosphorylation and glioblastoma cell proliferation.
Biochem Biophys Res Commun
2022
597:64-70
PubMed ID: 35124461
DOI: 10.1016/j.bbrc.2022.01.050
|
|
20564
Hayashima K, Katoh H.
Expression of gamma-glutamyltransferase 1 in glioblastoma cells confers resistance to cystine deprivation-induced ferroptosis.
J Biol Chem
2022
101703
PubMed ID: 35148992
DOI: 10.1016/j.jbc.2022.101703
|
|
20718
Ando S, Kojima N, Moyama C, Fujita M, Ohta K, Ii H, Nakata S.
JCI-20679 suppresses the proliferation of glioblastoma stem cells by activating AMPK and decreasing NFATc2 expression levels.
Mol Med Rep
2022
26(1)
PubMed ID: 35621135
DOI: 10.3892/mmr.2022.12754
|
|
20874
Mitobe Y, Nakagawa-Saito Y, Togashi K, Suzuki S, Sugai A, Matsuda KI, Sonoda Y, Kitanaka C, Okada M.
CEP-1347 Targets MDM4 Protein Expression to Activate p53 and Inhibit the Growth of Glioma Cells.
Anticancer Res
2022
42(10):4727-4733
PubMed ID: 36192008
DOI: 10.21873/anticanres.15977
|
|
13413
Hayashima K, Kimura I, Katoh H.
Role of ferritinophagy in cystine deprivation-induced cell death in glioblastoma cells.
Biochem Biophys Res Commun
2021
PubMed ID: 33421769
DOI: 10.1016/j.bbrc.2020.12.075
|
|
12999
Kinashi Y, Ikawa T, Takahashi S.
The combined effect of neutron irradiation and temozolomide on glioblastoma cell lines with different MGMT and P53 status.
Appl Radiat Isot
2020
PubMed ID: 32561044
DOI: 10.1016/j.apradiso.2020.109204
|
|
14294
Soeta K, Iuchi K, Hisatomi H, Yokoyama C.
Generation of Rat Monoclonal Antibody for Cytokeratin 18 by Immunization of Three-Dimensional-Cultured Cancer Cells
Monoclon Antib Immunodiagn Immunother
2020
39(6):199-203
PubMed ID: 33064594
DOI: 10.1089/mab.2020.0030
|
|
11332
Toyama M, Hamaoka Y, Katoh H.
EphA3 is up-regulated by epidermal growth factor and promotes formation of glioblastoma cell aggregates.
Biochem. Biophys. Res. Commun.
2019
PubMed ID: 30528229
DOI: 10.1016/j.bbrc.2018.12.002
|
|
11505
Kageyama-Yahara N, Yamamichi N, Takahashi Y, Takeuchi C, Matsumoto Y, Sakaguchi Y, Koike K.
Tandem repeats of the 5' flanking region of human MUC5AC have a role as a novel enhancer in MUC5AC gene expression.
Biochem Biophys Rep
2019
18:100632
PubMed ID: 30993217
DOI: 10.1016/j.bbrep.2019.100632
|
|
11581
Teramoto K, Katoh H.
The cystine/glutamate antiporter xCT is a key regulator of EphA2 S897 phosphorylation under glucose-limited conditions.
Cell. Signal.
2019
PubMed ID: 31152846
DOI: 10.1016/j.cellsig.2019.05.014
|
|
11624
Furuse Y, Chaimongkol N, Okamoto M, Oshitani H.
Evolutionary and Functional Diversity of the 5' Untranslated Region of Enterovirus D68: Increased Activity of the Internal Ribosome Entry Site of Viral Strains during the 2010s.
Viruses
2019
PubMed ID: 31288421
DOI: 10.3390/v11070626
|
|
11639
Taniguchi K, Ii H, Kageyama S, Takagi H, Chano T, Kawauchi A, Nakata S.
Depletion of gamma-glutamylcyclotransferase inhibits cancer cell growth by activating the AMPK-FOXO3a-p21 axis.
Biochem. Biophys. Res. Commun.
2019
PubMed ID: 31345573
DOI: 10.1016/j.bbrc.2019.07.049
|
|
10522
Haryu S, Saito R, Jia W, Shoji T, Mano Y, Sato A, Kanamori M, Sonoda Y, Sampetrean O, Saya H, Tominaga T.
Convection-enhanced delivery of sulfasalazine prolongs survival in a glioma stem cell brain tumor model.
J. Neurooncol.
2018
136:23-31
PubMed ID: 28929335
DOI: 10.1007/s11060-017-2621-7
|
|
10677
Yaekashiwa N, Otsuki S, Hayashi S, Kawase K.
Investigation of the non-thermal effects of exposing cells to 70-300 GHz irradiation using a widely tunable source.
J. Radiat. Res.
2018
59:116-121
PubMed ID: 29281029
DOI: 10.1093/jrr/rrx075
|
|
4071
Zhiwei Qiao, Tadashi Kondo
Identification of cephalomannine as a drug candidate for glioblastoma via high-throughput drug screening
Journal of Electrophoresis
2018
62:17
DOI: 10.2198/jelectroph.62.17
|
|
4125
Hamaoka Y, Negishi M, Katoh H.
Tyrosine kinase activity of EphA2 promotes its S897 phosphorylation and glioblastoma cell proliferation.
Biochem. Biophys. Res. Commun.
2018
PubMed ID: 29626472
DOI: 10.1016/j.bbrc.2018.04.020
|
|
9963
Kamemura K.
O-GlcNAc glycosylation stoichiometry of the FET protein family: only EWS is glycosylated with a high stoichiometry.
Biosci. Biotechnol. Biochem.
2017
81:541-546
PubMed ID: 27903134
DOI: 10.1080/09168451.2016.1263148
|
|
10559
Goji T, Takahara K, Negishi M, Katoh H.
Cystine uptake through the cystine/glutamate antiporter xCT triggers glioblastoma cell death under glucose deprivation.
J. Biol. Chem.
2017
292:19721-19732
PubMed ID: 29038291
DOI: 10.1074/jbc.M117.814392
|
|
7074
Hamaoka Y, Negishi M, Katoh H.
EphA2 is a key effector of the MEK/ERK/RSK pathway regulating glioblastoma cell proliferation.
Cell. Signal.
2016
28:937-45
PubMed ID: 27132626
DOI: 10.1016/j.cellsig.2016.04.009
|
|
10024
Matsumura K, Nakata S, Taniguchi K, Ii H, Ashihara E, Kageyama S, Kawauchi A, Yoshiki T.
Depletion of γ-glutamylcyclotransferase inhibits breast cancer cell growth via cellular senescence induction mediated by CDK inhibitor upregulation.
BMC Cancer
2016
16:748
PubMed ID: 27658708
DOI: 10.1186/s12885-016-2779-y
|
|
13760
Shoji T, Saito R, Chonan M, Shibahara I, Sato A, Kanamori M, Sonoda Y, Kondo T, Ishii N, Tominaga T.
Local convection-enhanced delivery of an anti-CD40 agonistic monoclonal antibody induces antitumor effects in mouse glioma models
Neuro Oncol
2016
18(8):1120-8
PubMed ID: 26917236
DOI: 10.1093/neuonc/now023
|
|
7557
Seki K, Kinashi Y, Takahashi S.
Influence of p53 status on the effects of boron neutron capture therapy in glioblastoma.
Anticancer Res.
2015
35:169-74
PubMed ID: 25550548
|
|
4947
Matsuda Y, Ishiwata T, Yoshimura H, Hagio M, Arai T.
Inhibition of nestin suppresses stem cell phenotype of glioblastomas through the alteration of post-translational modification of heat shock protein HSPA8/HSC71
Cancer Lett
2015
357(2):602-1
PubMed ID: 25527454
DOI: 10.1016/j.canlet.2014.12.030
|
|
19321
El-Ghlban S, Kasai T, Shigehiro T, Yin HX, Sekhar S, Ida M, Sanchez A, Mizutani A, Kudoh T, Murakami H, Seno M.
Chlorotoxin-Fc fusion inhibits release of MMP-2 from pancreatic cancer cells
Biomed Res Int
2014
2014:152659
PubMed ID: 24511528
DOI: 10.1155/2014/152659
|
|
7738
Sunayama J, Sato A, Matsuda K, Tachibana K, Watanabe E, Seino S, Suzuki K, Narita Y, Shibui S, Sakurada K, Kayama T, Tomiyama A, Kitanaka C.
FoxO3a functions as a key integrator of cellular signals that control glioblastoma stem-like cell differentiation and tumorigenicity.
Stem Cells
2011
29:1327-37
PubMed ID: 21793107
DOI: 10.1002/stem.696
|
|
7934
Matsuda Y, Kawamoto Y, Teduka K, Peng WX, Yamamoto T, Ishiwata T, Naito Z.
Morphological and cytoskeletal alterations of nervous system tumor cells with different culturing methods.
Int. J. Oncol.
2011
38:1253-8
PubMed ID: 21331444
DOI: 10.3892/ijo.2011.945
|
|
8024
Tahara K, Kato Y, Yamamoto H, Kreuter J, Kawashima Y.
Intracellular drug delivery using polysorbate 80-modified poly(D,L-lactide-co-glycolide) nanospheres to glioblastoma cells.
J Microencapsul
2011
28:29-36
PubMed ID: 21171814
DOI: 10.3109/02652048.2010.522258
|
|
16653
Liu Y, Liang Y, Zheng T, Yang G, Zhang X, Sun Z, Shi C, Zhao S.
Inhibition of heme oxygenase-1 enhances anti-cancer effects of arsenic trioxide on glioma cells
J Neurooncol
2011
104(2):449-58
PubMed ID: 21327864
DOI: 10.1007/s11060-010-0513-1
|
|
8111
Sunayama J, Sato A, Matsuda K, Tachibana K, Suzuki K, Narita Y, Shibui S, Sakurada K, Kayama T, Tomiyama A, Kitanaka C.
Dual blocking of mTor and PI3K elicits a prodifferentiation effect on glioblastoma stem-like cells.
Neuro-oncology
2010
12:1205-19
PubMed ID: 20861085
DOI: 10.1093/neuonc/noq103
|
|
8338
Yamashita Y, Kasugai I, Sato M, Tanuma N, Sato I, Nomura M, Yamashita K, Sonoda Y, Kumabe T, Tominaga T, Katakura R, Shima H.
CDC25A mRNA levels significantly correlate with Ki-67 expression in human glioma samples.
J. Neurooncol.
2010
100:43-9
PubMed ID: 20217459
DOI: 10.1007/s11060-010-0147-3
|
|
8297
Sunayama J, Matsuda K, Sato A, Tachibana K, Suzuki K, Narita Y, Shibui S, Sakurada K, Kayama T, Tomiyama A, Kitanaka C.
Crosstalk between the PI3K/mTOR and MEK/ERK pathways involved in the maintenance of self-renewal and tumorigenicity of glioblastoma stem-like cells.
Stem Cells
2010
28(11):1930-9
PubMed ID: 20857497
DOI: 10.1002/stem.521
|
|
14324
Gene expression profile changes correlating with radioresistance in human cell lines
Gene expression profile changes correlating with radioresistance in human cell lines
Int J Radiat Oncol Biol Phys
2006
65(1):234-4
PubMed ID: 16618578
DOI: 10.1016/j.ijrobp.2005.12.048
|
Back
Top
CELL BANK Website
